Importantly, MMP‐9 knockdown and inhibition are well tolerated with no body weight loss observed in the SW620 xenograft model (Fig. 7C,I), suggesting that they may be useful for effective colon cancer therapy. This evidence concerns the gene MMP9 and colonic neoplasm.